参考文献/References:
[1] Stankovic S, Obradovic S, Dzudovic B, et al.Lower plasma protein C activity is associated with early myocardial necrosis and noreflow phenomenon in patients with ST elevation myocardial infarction[J].Acta Cardiol,2018,11(9):1-9.
[2] 陈 峰,庞继恩,孙 强,等.急性心肌梗死患者冠状动脉循环血清高肌钙蛋白T含量变化及意义[J].中国心血管病研究,2012,10(5):355-357.
[3] Antoni ML,Hoogslag GE,Boden H,et al.Cardiovascular mortality and heart failure risk score for patients after STsegment elevation acute myocardial infarction treated with primary percutaneous coronary intervention (Data from the Leiden MISSION! Infarct Registry)[J].Am J Cardiol,2012,109(2):187-194.
[4] 边召允.血清N端脑钠肽前体,心肌肌钙蛋白T及超敏C反应蛋白水平变化对心力衰竭患者诊断的临床意义[J].医学检验与临床,2015,26(5):69-70,72.
[5] AbdelDayem K, Eweda II, ElSherbiny A,et al.Cutoff value of admission nterminal probrain natriuretic peptide which predicts poor myocardial perfusion after primary percutaneous coronary intervention for stsegmentelevation myocardial infarction[J].Acta Cardiol Sin,2016 ,32(6):649-655.
[6] 蔡天志,张科林,张安吉,等.急性心肌梗死后急性心力衰竭患者血中卵泡抑素样蛋白1的变化及临床意义[J].山西医药杂志,2015,44(9):971-973.
[7] Ponikowski P, Voors AA, Anker SD, et al.2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure[J].Rev Esp Cardiol (Engl Ed),2016,69(12):1167.
[8] Okabe T,Yakushiji T,Shimazu S,et al.Serum zinc concentration in patients with acute myocardial infarction in percutaneous coronary intervention era[J].PLoS One,2018,13(8):e0203074.
[9] 吴文凤.AMI患者治疗前后血浆BNP、ANP、CKMB的变化及其临床意义[J].西南国防医药,2016,26(1):1720.
[10] Kim MC, Jeong MH, Sim DS, et al.Optimal timing of percutaneous coronary intervention in patients with nonstsegment elevation myocardial infarction complicated by acute decompensated heart failure (from the korea acute myocardial infarction registrynational institutes of health\[KAMIRNIH\])[J].Am J Cardiol,2018,121(11):12851292.
[11] 曹钏宏,方雪红,徐 博.心电图结合脑钠肽检测对老年急性左心衰患者预后临床观察[J].陕西医学杂志,2015,46(7):886887,888.
[12] 齐延伟,吴忠荣,马振刚,等.参麦配合瑞通立治疗急性心肌梗塞ST 段抬高型及对心室功能和血浆脑钠肽水平的影响[J].陕西中医,2015,34(5):562564.
[13] 陈 佳.sST2和NTproBNP对AMI合并心力衰竭患者预后、诊断价值评估[J].医学综述,2015,21(23):43904392.
[14] Yancy CW,Jessup M,Bozkurt B,et al.2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines[J].Circulation,2013,128(16):18101852.
[15] 吴秀娟,王忠民,刘煜昊,等.血清生物标记物对急性心肌梗死患者院内心功能衰竭的预测价值[J].岭南心血管病杂志,2017,23(5):511515,520.
[16] Kristensen SL,Preiss D,Jhund PS,et al.Risk related to prediabetes mellitus and diabetes mellitus in heart failure with reduced ejection fraction: insights from prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial[J].Circ Heart Fail,2016,9(1):e002560.
[17] 邓诗武.GDF15、cTnⅠ、BNP在急性心肌梗死病人中的关系及对其近期预后的预测价值[J].中西医结合心脑血管病杂志,2017,15(18):22942296.
[18] 赵旭林,张 琳,侯慧云.脑钠肽、高敏C反应蛋白、血尿酸与老年慢性心力衰竭相关性研究[J].陕西医学杂志,2013,42(8):10491050.
[19] 中国医学前沿杂志编辑部.《急性ST段抬高型心肌梗死溶栓治疗的合理用药指南》第2版在京发布[J].中国医学前沿杂志:电子版,2018,10(12):95.
[20] 张晓华.60例非ST段抬高型急性心肌梗死患者临床特征及预后分析[J].数理医药学杂志,2019,32(1):911.
[21] 魏 来.急性心肌梗死患者PCI术后主要不良心血管事件发生的影响因素[J].心血管康复医学杂志,2018,27(6):633637.
[22] 贾圣英,谢莲娜,王凯君,等.不同年龄段急性冠状动脉综合征患者临床及预后分析[J].心脑血管病防治,2018,18(6):448451.
[23] 姚自鹏,王 琳,宗 政,等.缺血后适应在急性心肌梗死介入治疗中的研究进展[J].中国老年学杂志,2018,38(21):53685371.
相似文献/References:
[1]陈伟国,张晓萌,常 盼,等.阿托伐他汀对2型糖尿病心肌病患者心功能、脑钠肽、超敏C反应蛋白影响临床研究*[J].陕西医学杂志,2019,(1):10.
CHEN Weiguo,ZHANG Xiaomeng,CHANG Pan,et al.Clinical research of atorvastatinon on cardiacfunction,brain natriuretic peptide and hypersensitive Creactive protein in patients with diabetic cardiomyopathies[J].,2019,(5):10.
[2]路 飞,王妍妍△,胡 涛.不同起源频发室性早搏患者射频消融术后左心房功能及结构变化临床研究*[J].陕西医学杂志,2019,(12):1642.
LU Fei,WANG Yanyan,HU Tao..Clinical study on left atrial function and structure changes in patients with frequent premature ventricular contractions of different origins after RFCA[J].,2019,(5):1642.
[3]耿 鹃,周 耀,刘旭辉.微小RNA-492、红细胞微粒水平与ST段抬高型急性心肌梗死患者冠状动脉病变严重程度关系研究[J].陕西医学杂志,2024,(9):1249.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.021]
GENG Juan,ZHOU Yao,LIU Xuhui.Relationship between level of miR-492,erythrocyte microparticles and severity of coronary artery lesions in STEMI patients[J].,2024,(5):1249.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.021]